High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
about
Bovine milk in human nutrition--a reviewRosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveWaist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional studyLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsIs the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysisClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseComponents of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular diseaseVery Long (> 48 hours) Shifts and Cardiovascular Strain in Firefighters: a Theoretical FrameworkBehavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise trainingHigh-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneDisturbed sleep is associated with increased C-reactive protein in young women.Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study.Epidemiology and management of antiretroviral-associated cardiovascular disease.Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' diseaseAssociation of C-reactive protein with cognitive impairment.Elevated salivary C-reactive protein levels are associated with active and passive smoking in healthy youth: A pilot study.A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial).Obstructive sleep apnea is associated with increased urinary albumin excretion.Myocardial ischemia, reperfusion, and infarction in chronically instrumented, intact, conscious, and unrestrained miceImmunomodulating effects of vitamin D analogs in hemodialysis patients.Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15.Effect of periodontal treatment on serum C-reactive protein levels: a systematic review and meta-analysis.Effect of exercise training on chronic inflammation.Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.Impaired retinal vasodilator responses in prediabetes and type 2 diabetes.Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.Adiposity, type 2 diabetes, and Alzheimer's diseaseSerum C-Reactive Protein (CRP), Target for Therapy or Trouble?Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.Association of C-reactive protein and HIV infection with acute myocardial infarction.Impact of environmental tobacco smoke exposure in women on oxidative stress in the antral follicle and assisted reproduction outcomes.A significant correlation between C - reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions.High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum.Using lectins to harvest the plasma/serum glycoproteome.Perspectives on the value of biomarkers in acute cardiac care and implications for strategic managementEffect of yoga training on inflammatory cytokines and C-reactive protein in employees of small-scale industries.Psoriasis as a human model of disease to study inflammatory atherogenesis.GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease.
P2860
Q21245683-D812CCBE-3205-4A4E-A860-FC37C0B267FFQ24594814-CADF3B8C-EAAD-4C00-B516-B8C1369D1FDDQ24633407-6C438AC2-1662-4D47-8CDD-08E170283D49Q26777871-155E4B5B-62B6-47AA-9FE8-F16FD9382B76Q28078709-57A8B926-8267-48BB-8ADF-078BFE55FE55Q28218124-F490D55E-368C-48E9-8B56-51689057F9EDQ28222399-08D84B2E-D022-4953-A215-324B8B8DB53BQ28384493-CB08406B-F5D7-40AB-930E-F6BC8AED2047Q33938878-037B5C98-4AA0-434C-8FFA-6BBFE5F8009CQ33979763-09B00D6E-46CF-4EE2-9B60-5B2E54C00B70Q34018726-14C76747-D690-4925-BAAD-9FC826C9A928Q34040520-DECBE98C-429F-459F-870C-713FCDE397C8Q35338096-662F793E-8C85-40AD-B31C-3E7DE9A4C7DBQ35410782-B1A5EC85-D579-4D59-A772-DB4D102EAD2BQ35591752-33CF1699-3C6E-4C21-AECC-FC9991E988F5Q35698121-9E4622A4-7CF0-4094-BA95-CDF3621C4099Q35861592-F19E54AE-8186-4919-8C67-EA8C404C7584Q35995542-AC042688-D147-4BA8-B2F1-C95D7EA5F06FQ36042854-C2D2D12B-B8F9-4896-8ABD-E10D2885D00CQ36285501-44CC6190-8EEF-4EE7-93B0-902EC8488B0CQ36585256-4F35430A-9F79-44DE-8B08-E62EB1CD7D2AQ36619599-6026A8D7-30E7-4C8D-BA40-23BF1E9A4371Q36776663-5391E2C1-2ED3-4CD1-9FC2-DECD4EB7B086Q36814772-7303EA26-D5E4-4828-B7AA-4FE62F4AF83DQ37110310-3348522E-F04C-41FE-A0DD-5B7ACDE6A6FFQ37192801-32C395C3-91D2-4066-81D3-276E78EA308EQ37250859-BF38DFCD-9321-42AC-BE56-AC0AAA2A128EQ37277917-014D0944-892D-401A-9A82-FA676A719224Q37364862-3B978024-C08F-4D8B-A465-378574B089FEQ37380902-67354B79-3189-4E1D-BBBE-27714FF478F4Q37390630-DE235EDA-E575-4185-A4EF-792581D06065Q37413792-015EF9F9-76EC-4978-BD1E-E937037882E8Q37621931-F21B3FCF-9657-4770-99CA-80A5937CBF19Q37709537-C2678D21-34CC-4145-A7B7-9C6B6FB54DC8Q38022218-5A51B8A2-15AA-470B-B693-A6C42E2353E6Q38138969-F3DED8E3-5630-4D86-AC42-7D29D0F23CD3Q38601273-2C20DB0E-F2DD-4407-9090-67F421ACAAFEQ39160397-A60C794E-4C04-4B9E-B639-B08CC6CE852FQ40571559-8AC90FE3-EB92-45C3-BE02-12A2A065CF90Q40840356-7576B7DC-CB0D-472C-8D6B-FA7552721CDA
P2860
High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
High-sensitivity C-reactive pr ...... practice to clinical benefit.
@en
type
label
High-sensitivity C-reactive pr ...... practice to clinical benefit.
@en
prefLabel
High-sensitivity C-reactive pr ...... practice to clinical benefit.
@en
P1476
High-sensitivity C-reactive pr ...... practice to clinical benefit.
@en
P2093
Paul M Ridker
P304
P356
10.1016/J.AHJ.2004.04.028
P407
P433
P577
2004-07-01T00:00:00Z